Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ZIMLAB | NSE
0.21
0.31%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
07/04/2026
68.66
67.10
69.50
67.10
ZIM Laboratories Limited develops manufactures and supplies generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations using modified release patterns in the oral solid dosage forms such as granules pellets taste-masked powders suspensions tablets capsules dry syrup and oral thin films. It offers therapeutics in the areas of urology gastroenterology CNS antibiotics anti-infectives NSAIDs/pain analgesics and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur India.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
62.4%1 month
73.6%3 months
56.8%6 months
56.1%29.93
-
2.29
0.46
0.24
13.31
1.75
-
410.37M
3.35B
36.17M
-
3.78
260.00
21.30
7.86
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
10.19
Range1M
14.69
Range3M
22.04
Rel. volume
0.30
Price X volume
1.85M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 39.56 | 3.15B | 4.85% | 45.53 | 15.37% |
| Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 225.58 | 2.78B | -0.27% | 82.74 | 15.37% |
| Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 114.2 | 2.72B | 3.12% | 674.92 | 30.17% |
| Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 9.98 | 2.26B | -0.30% | 138.07 | 59.44% |
| Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 131.09 | 2.12B | -1.58% | 42.44 | 17.95% |
| Lyka Labs Limited | LYKALABS | Biotechnology | 58.81 | 2.10B | 8.11% | 813.94 | 86.05% |
| Brooks Laboratories Limited | BROOKS | Drug Manufacturers-Specialty & Generic | 73.23 | 1.95B | 14.33% | n/a | 8.60% |
| Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 59.2 | 1.71B | 4.98% | 32.75 | 23.61% |
| Alpa Laboratories Limited | ALPA | Drug Manufacturers-Specialty & Generic | 69.32 | 1.47B | 11.63% | 13.54 | 3.45% |
| Krebs Biochemicals & Industries Limited | KREBSBIO | Drug Manufacturers-Specialty & Generic | 61.8 | 1.33B | 8.14% | n/a | -162.25% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Madhav Copper Limited | MCL | Copper | 60.96 | 1.68B | -1.93% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 86.56 | 1.26B | 1.54% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 71.53 | 797.47M | 2.49% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.84 | 396.50M | 0.22% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7 | 153.37M | 0.57% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 13.31 | 24.85 | Cheaper |
| Ent. to Revenue | 1.75 | 11.40 | Cheaper |
| PE Ratio | 29.93 | 51.36 | Cheaper |
| Price to Book | 2.29 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 56.77 | 42.17 | Riskier |
| Debt to Equity | 0.46 | 0.35 | Expensive |
| Debt to Assets | 0.24 | 0.17 | Expensive |
| Market Cap | 3.35B | 290.82B | Emerging |